A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA. 2003 Dec 03; 290(21):2805-16.

View in: PubMed

subject areas

Adrenergic beta-Antagonists
Aged
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Atenolol
Blood Pressure
Calcium Channel Blockers
Coronary Artery Disease
Diuretics
Drug Therapy, Combination
Female
Heart Rate
Humans
Hydrochlorothiazide
Hypertension
Indoles
Male
Middle Aged
Sodium Chloride Symporter Inhibitors
Treatment Outcome
Verapamil

authors with profiles

George Bakris